started · updated
Gene-editing treatment reduces cholesterol by 50% for over one year
Scientists have reported that a single-dose gene-editing treatment using CRISPR-Cas9 can significantly and durably reduce cholesterol levels. Results from a small pilot study of 15 patients, published in The New England Journal of Medicine, indicate that the intervention may offer a long-term solution for managing high cholesterol.
In the group receiving the highest dose, patients experienced an approximately 50% reduction in LDL (bad) cholesterol and a substantial decrease in triglycerides. Follow-up data showed that these reductions, which were evident 60 days after the infusion, persisted for more than one year without significant adverse effects.
Researchers from the United States, Australia, and New Zealand emphasize that while these preliminary results are promising, larger clinical trials are necessary to confirm the safety and efficacy of the treatment before it becomes a standard medical option.
Entities
CRISPR-Cas9 · Cleveland Clinic · Dr. Luke Laffin · Dr. Steven Nissen · Luke Laffin · New England Journal of Medicine · Steven Nissen
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 6 SOURCES] The treatment utilizes CRISPR-Cas9 gene-editing technology. abc17news.com · www.catalunyapress.cat · keyt.com · kioncentralcoast.com · localnews8.com
- [● 8 SOURCES] The pilot study included 15 patients with dangerously high cholesterol levels. abc17news.com · www.catalunyapress.cat · diario.mx · dol.com.br · keyt.com · +2 more
- [● 8 SOURCES] LDL cholesterol and triglyceride reductions observed 60 days post-treatment persisted for over one year. abc17news.com · www.catalunyapress.cat · diario.mx · dol.com.br · keyt.com · +2 more
- [● 8 SOURCES] The experimental treatment reduced LDL cholesterol by approximately 50% in patients receiving the highest dose. abc17news.com · www.catalunyapress.cat · diario.mx · dol.com.br · keyt.com · +2 more
- [○ 1 SOURCE] In the highest dose group, triglycerides decreased by 55% at two months and 48% after one year. www.catalunyapress.cat